Lymphoma Trial, Recruiting NCT07191431 Sponsor: Ruijin Hospital Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT07191431
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 14 and 80 years old.
  • People with a confirmed diagnosis of B-cell lymphoma affecting the central nervous system (brain or spinal cord), confirmed through tissue or fluid testing.
  • People whose lymphoma has come back or has not responded to treatment, and who have received at least one previous treatment targeting the disease in the central nervous system.
  • People whose life expectancy is judged by the investigating doctor to be more than 3 months.
  • People whose side effects from previous treatments have mostly resolved to a mild or normal level (hair loss is an exception and does not need to have resolved).
  • People whose blood counts, liver, kidney, and clotting function meet certain minimum levels as measured by blood tests, without having needed blood transfusions, growth factor injections, or corrective medications in the 14 days before screening (confirm with trial site for specific values).
  • People who are willing and able to follow all trial schedules, appointments, and procedures.
  • People who are willing to use effective contraception throughout the trial and for 3 months after treatment ends, if there is any possibility of becoming pregnant or fathering a child. Male participants must also avoid sperm donation during this period.
  • People who fully understand the trial and agree to take part by signing a consent form (or whose legal guardian signs on their behalf).

Who may not be able to join:

  • People who have a known allergy or medical reason preventing them from taking any of the drugs used in this trial.
  • People with a history of active liver disease, including active hepatitis B (based on virus levels in the blood), cirrhosis, or active hepatitis C (based on specific blood test results).
  • People who have HIV infection.
  • People with significant heart failure, or who have had a heart attack, unstable chest pain, stroke, or mini-stroke in the past six months.
  • People with a hereditary condition causing abnormal heart rhythm, or whose heart rhythm measurement (QTc interval) is above a certain level on an electrocardiogram.
  • People who are pregnant, breastfeeding, or planning to become pregnant during the trial period.
  • People with a significant history of neurological or psychiatric conditions, or a history of abusing certain medications or substances.
  • People with a clinically significant active infection at the time of joining.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 15214370575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
22 September 2025
Est. completion
2 September 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

ORR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov